by Maria S. Rueda, MD; Renzo Calderon-Anyosa, MD; Jorge Gonzales, MD; Christie G. Turin, MD; Alonso Zea-Vera, MD; Jaime Zegarra, MD; Sicilia Bellomo, MD; Luis Cam, MD; Anne Castaneda, MD; and Theresa J. Ochoa, MD, on behalf of the NEOLACTO Research Group
To be published in The Pediatric Infectious Disease Journal, March 2019. doi: 10.1097/INF.0000000000002055
Neonatal sepsis is a leading cause of child morbidity and mortality, especially in premature and low birth weight infants. Prompt antibiotic therapy is warranted, but its inappropriate use leads to bacterial resistance and adverse outcomes. This study aims to describe the antibiotic use for late-onset sepsis in Peruvian premature infants.